Market Insights

"The global drug discovery informatics market size was estimated at USD 2.32 billion in 2021 and is likely to grow at a CAGR of 9.23% during 2022-2028 to reach USD 4.35 billion in 2028."

Want to know more about the market scope? Register Here

Drug discovery informatics encompasses the creation of systems that can work more capably with large sets of clinical trial and treatment data. Discovery and development of drugs is a highly complex process, requiring the creation of large amounts of data and information.

Market Dynamics

Market Drivers

The prime factors that are likely to drive the market are the increasing expenditure in R&D activities, growing support for research in the pharmaceutical areas, especially for rare diseases, and the escalating use of informatics for discovery of new drugs.

Segments Analysis

Function Trends

"The sequencing & target data analysis segment accounted for the largest market share."

The market is segmented as sequencing & target data analysis, docking, molecular modeling, library & database preparation, and others. The sequencing & target data analysis segment held the largest share of the market in 2021, owing to the increased application of sequencing analysis and ease of handling information from different sources and domains. The segment is likely to maintain its leading position during the forecast period as well.

End-User Trends

"The pharmaceutical companies segment accounted for the largest market share."

The drug discovery informatics market is segmented as pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and others. The pharmaceutical companies segment led the market in 2021 and is expected to dominate the market over the forecast period. The growth of the segment is driven by the extensive use of software for pre-clinical research & developmental activities, target identification, compound screening and lead identification, and streamlining drug discovery processes.

Regional Insights

"North America accounted for the largest market share."

North America held the largest share of the market in 2021, followed by Europe. North America is expected to command the market during the forecast period as well. The dominant position of North America is due to the presence of major CROs and increasing expenditure by pharmaceutical and biopharmaceutical companies.

Asia-Pacific is likely to grow at the highest CAGR during the forecast period, driven by the rapid growth of pharmaceutical and biopharmaceutical industries and a growing number of CROs in the region, with China and India being the major countries offering promising growth opportunities over the forecast period.

Know the high-growth countries in this report. Register Here

Key Players

The following are the key players in the drug discovery informatics market (arranged alphabetically).

• Accenture PLC
• Albany Molecular Research Inc.
• Charles River Laboratories International, Inc.
• Clarivate Analytics LLC
• Eurofins Scientific SE
• IBM Corporation
• Jubilant Life Sciences Limited
• PerkinElmer Inc.
• Schrödinger, Inc.
• Thermo Fisher Scientific Inc.

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at [email protected]

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s drug discovery informatics market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].